VRNA logo

Verona Pharma (VRNA) Cash From Operations

Annual CFO

-$122.20 M
-$71.98 M-143.33%

December 31, 2024

Summary

Performance

1-Year Change

-143.33%

3-Year Change

-267.48%

5-Year Change

-185.07%

15-Year Change

-336.93%

VRNA Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.45%
VRNA annual cash flow from operations is higher than 11.45% of companies in Healthcare sector

High & Low

All-time High

$3400.00
VRNA annual cash flow from operations is currently <-9900.00% below its historical high of $3400.00

3-Year Low

-$122.20 M
VRNA annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
VRNA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
VRNA next annual earnings announcement has not yet been scheduled

OtherVRNAcash flowmetrics:

Annual CFI

-$580.00 K
VRNA annual cash flow from investing activities is -$580.00 thousand

Annual CFF

$250.78 M
VRNA annual cash flow from financing activities is $250.78 million

Annual FCF

-$122.78 M
VRNA annual free cash flow is -$122.78 million

Annual CAPEX

$580.00 K
VRNA annual capital expenditures is $580.00 thousand

Quarterly CFO

-$28.84 M
+$33.82 M+53.98%

December 31, 2024

Summary

Performance

3-Month Change

+53.98%

1-Year Change

-177.22%

3-Year Change

-177.22%

5-Year Change

-177.22%

VRNA Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

13.87%
VRNA quarterly cash flow from operations is higher than 13.87% of companies in Healthcare sector

High & Low

All-time High

$22.82 M
VRNA quarterly cash flow from operations is currently -226.34% below its historical high of $22.82 million

3-Year Low

-$62.66 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
VRNA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
VRNA next earnings announcement is scheduled for May 9, 2025

OtherVRNAcash flowmetrics:

Quarterly CFI

-$535.00 K
VRNA quarterly cash flow from investing activities is -$535.00 thousand

Quarterly CFF

$94.16 M
VRNA quarterly cash flow from financing activities is $94.16 million

Quarterly FCF

-$29.37 M
VRNA quarterly free cash flow is -$29.37 million

Quarterly CAPEX

$535.00 K
VRNA quarterly capital expenditures is $535.00 thousand

TTM CFO

-$122.20 M
-$18.43 M-17.76%

December 31, 2024

Summary

Performance

3-Month Change

-17.76%

1-Year Change

-143.33%

3-Year Change

-143.33%

5-Year Change

-143.33%

VRNA TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.57%
VRNA TTM cash flow from operations is higher than 11.57% of companies in Healthcare sector

High & Low

All-time High

-$4.41 M

3-Year Low

-$122.20 M
VRNA TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
VRNA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
VRNA next earnings announcement is scheduled for May 9, 2025

OtherVRNAcash flowmetrics:

TTM CFI

-$580.00 K
VRNA TTM cash flow from investing activities is -$580.00 thousand

TTM CFF

$250.78 M
VRNA TTM cash flow from financing activities is $250.78 million

TTM FCF

-$122.78 M
VRNA TTM free cash flow is -$122.78 million

TTM CAPEX

$580.00 K
VRNA TTM capital expenditures is $580.00 thousand

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

VRNA Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-143.3%-177.2%-143.3%
3 y3 years-267.5%-177.2%-143.3%
5 y5 years-185.1%-177.2%-143.3%

VRNA Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-267.5%at low-398.7%+54.0%-328.4%at low
5 y5-year-267.5%at low-226.3%+54.0%-328.4%at low
alltimeall time<-9999.0%at low-226.3%+54.0%-2672.2%at low

Verona Pharma Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$122.20 M(+143.3%)
-$28.84 M(-54.0%)
-$122.20 M(+17.8%)
Sep 2024
-
-$62.66 M(+266.4%)
-$103.77 M(+92.7%)
Jun 2024
-
-$17.10 M(+25.7%)
-$53.84 M(-7.3%)
Mar 2024
-
-$13.61 M(+30.8%)
-$58.05 M(+15.6%)
Dec 2023
-$50.22 M(-16.1%)
-$10.40 M(-18.3%)
-$50.22 M(+5.6%)
Sep 2023
-
-$12.73 M(-40.3%)
-$47.56 M(-10.1%)
Jun 2023
-
-$21.31 M(+268.6%)
-$52.93 M(+3.5%)
Mar 2023
-
-$5.78 M(-25.3%)
-$51.13 M(-14.6%)
Dec 2022
-$59.86 M(+80.0%)
-$7.74 M(-57.2%)
-$59.86 M(-13.8%)
Sep 2022
-
-$18.09 M(-7.3%)
-$69.45 M(+143.4%)
Jun 2022
-
-$19.52 M(+34.5%)
-$28.53 M(-2.4%)
Mar 2022
-
-$14.51 M(-16.2%)
-$29.21 M(-12.1%)
Dec 2021
-$33.25 M(-26.2%)
-$17.32 M(-175.9%)
-$33.25 M(-4.2%)
Sep 2021
-
$22.82 M(-213.0%)
-$34.73 M(-48.6%)
Jun 2021
-
-$20.20 M(+8.9%)
-$67.55 M(+34.0%)
Mar 2021
-
-$18.55 M(-1.3%)
-$50.40 M(+11.8%)
Dec 2020
-$45.08 M(+5.2%)
-$18.80 M(+88.0%)
-$45.08 M(+19.1%)
Sep 2020
-
-$10.00 M(+226.6%)
-$37.83 M(+4.4%)
Jun 2020
-
-$3.06 M(-76.9%)
-$36.24 M(-16.2%)
Mar 2020
-
-$13.22 M(+14.5%)
-$43.23 M(+0.8%)
Dec 2019
-$42.87 M
-$11.55 M(+37.5%)
-$42.87 M(+15.0%)
Sep 2019
-
-$8.40 M(-16.4%)
-$37.29 M(+25.3%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$10.05 M(-21.9%)
-$29.75 M(+9.8%)
Mar 2019
-
-$12.86 M(+115.5%)
-$27.11 M(+17.9%)
Dec 2018
-$22.98 M(-17.8%)
-$5.97 M(+585.6%)
-$22.98 M(-3.6%)
Sep 2018
-
-$870.80 K(-88.2%)
-$23.83 M(-28.9%)
Jun 2018
-
-$7.40 M(-15.3%)
-$33.50 M(+3.7%)
Mar 2018
-
-$8.74 M(+28.1%)
-$32.30 M(+15.5%)
Dec 2017
-$27.97 M(+305.8%)
-$6.82 M(-35.3%)
-$27.97 M(+32.3%)
Sep 2017
-
-$10.54 M(+69.9%)
-$21.15 M(+99.3%)
Jun 2017
-
-$6.20 M(+40.7%)
-$10.61 M(+140.7%)
Mar 2017
-
-$4.41 M
-$4.41 M
Dec 2016
-$6.89 M(-26.8%)
-
-
Dec 2015
-$9.42 M(+70.9%)
-
-
Dec 2014
-$5.51 M(+62.7%)
-
-
Dec 2013
-$3.39 M(-17.0%)
-
-
Dec 2012
-$4.08 M(+67.0%)
-
-
Dec 2011
-$2.44 M(-4.6%)
-
-
Dec 2010
-$2.56 M(-2.3%)
-
-
Dec 2009
-$2.62 M(+32.6%)
-
-
Dec 2008
-$1.98 M(-17.3%)
-
-
Dec 2007
-$2.39 M(+247.5%)
-
-
Dec 2006
-$687.70 K(<-9900.0%)
-
-
Dec 2005
$3400.00
-
-

FAQ

  • What is Verona Pharma annual cash flow from operations?
  • What is the all time high annual CFO for Verona Pharma?
  • What is Verona Pharma annual CFO year-on-year change?
  • What is Verona Pharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Verona Pharma?
  • What is Verona Pharma quarterly CFO year-on-year change?
  • What is Verona Pharma TTM cash flow from operations?
  • What is the all time high TTM CFO for Verona Pharma?
  • What is Verona Pharma TTM CFO year-on-year change?

What is Verona Pharma annual cash flow from operations?

The current annual CFO of VRNA is -$122.20 M

What is the all time high annual CFO for Verona Pharma?

Verona Pharma all-time high annual cash flow from operations is $3400.00

What is Verona Pharma annual CFO year-on-year change?

Over the past year, VRNA annual cash flow from operations has changed by -$71.98 M (-143.33%)

What is Verona Pharma quarterly cash flow from operations?

The current quarterly CFO of VRNA is -$28.84 M

What is the all time high quarterly CFO for Verona Pharma?

Verona Pharma all-time high quarterly cash flow from operations is $22.82 M

What is Verona Pharma quarterly CFO year-on-year change?

Over the past year, VRNA quarterly cash flow from operations has changed by -$18.43 M (-177.22%)

What is Verona Pharma TTM cash flow from operations?

The current TTM CFO of VRNA is -$122.20 M

What is the all time high TTM CFO for Verona Pharma?

Verona Pharma all-time high TTM cash flow from operations is -$4.41 M

What is Verona Pharma TTM CFO year-on-year change?

Over the past year, VRNA TTM cash flow from operations has changed by -$71.98 M (-143.33%)